Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer

Conditions:   Adenocarcinoma of the Gastroesophageal Junction;   Gastric Adenocarcinoma;   Gastric Squamous Cell Carcinoma;   Metastatic Malignant Neoplasm in the Stomach;   Stage IV Esophageal Adenocarcinoma;   Stage IV Esophageal Squamous Cell Carcinoma
Interventions:   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
Not yet recruiting - verified July 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/29DCXps
via IFTTT